Hematologic Oncology Update
Hematologic Oncology Update
✓

Relapsed/Refractory Multiple Myeloma — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute

· menunjukkan nota
01:02:25
Podcasts
RSS
Link

MENGENAI EPISOD INI

Featuring perspectives from Dr Sagar Lonial and Dr Paul G Richardson, including the following topics:

  • Multiple Myeloma (0:00)
  • Introduction: ESMO 2026; Recent FDA Approvals (1:53)
  • Chimeric Antigen Receptor T-Cell Therapy — Dr Lonial (2:46)
  • Bispecific Antibodies — Dr Lonial (19:16)
  • Antibody-Drug Conjugates — Dr Richardson (37:08)
  • Up-Front Treatment; Cereblon E3 Ligase Modulators — Dr Richardson (50:10)

CME information and select publications

Sains
Ubat-ubatan
Bahasa Inggeris
Amerika Syarikat
GunakanAPIuntuk mengambil episod ini dalamJSON

DALAM EPISOD INI

Edit tag ini

Tunjukkan NOTA 🔗

00:00:00Multiple Myeloma
00:01:53Introduction: ESMO 2026; Recent FDA Approvals
00:02:46Chimeric Antigen Receptor T-Cell Therapy — Dr Lonial
00:19:16Bispecific Antibodies — Dr Lonial
00:37:08Antibody-Drug Conjugates — Dr Richardson
00:50:10Up-Front Treatment; Cereblon E3 Ligase Modulators — Dr Richardson

TRANSKRIP 🔗

Are you the producer of this podcast? Add a podcast transcript
Need Audio-to-Text? Transcribe with Listen411 in Just 60 Seconds

CARI EPISOD LEPAS

Cari episod lepas bagi Hematologic Oncology Update.
Masukkan bar carian ini ke laman web anda

EPISOD LAIN DALAM PODCAST INI

Diffuse Large B-Cell Lymphoma — Proceedings from a Symposium Held in Conjunction with the American Oncology Network

Diffuse Large B-Cell Lymphoma — Proceedings from a Symposium Held in Conjunction with the American Oncology Network

Featuring perspectives from Dr Ann LaCasce and Dr Stephen "Fred" Divers, moderated by Dr Divers, including the following topics: Introduction (0:00) First-Line Treatment (1:33) Bispecific Antibodies and Chimeric Antigen Receptor T-Cell Therapy (20:36) CME information and select publications
00:50:22
KONGSI
SIMPAN
Chronic Lymphocytic Leukemia — Investigators Discuss Optimal Management

Chronic Lymphocytic Leukemia — Investigators Discuss Optimal Management

Featuring perspectives from Dr Catherine C Coombs and Dr Matthew S Davids, including the following topics: Introduction (0:00) Minimal Residual Disease Assays in Community-Based Practice (1:24) New Developments in Previously Untreated Chronic Lymphocytic Leukemia (CLL) — Dr Davids (8:12) Richte ...
00:58:15
KONGSI
SIMPAN
Diffuse Large B-Cell Lymphoma — An Interview with Dr L Elizabeth Budde on Employing CD20 x CD3 Bispecific Antibodies

Diffuse Large B-Cell Lymphoma — An Interview with Dr L Elizabeth Budde on Employing CD20 x CD3 Bispecific Antibodies

Featuring an interview with Dr L Elizabeth Budde, including the following topics: Considerations for selecting between bispecific antibodies (BsAbs); monotherapy versus combination therapy (0:00) Management of BsAb-induced cytokine release syndrome and other toxicities (7:35) Use of BsAbs in th ...
00:47:06
KONGSI
SIMPAN
Relapsed/Refractory Multiple Myeloma — Proceedings from a Session Held During the Society of Hematologic Oncology 2026 Annual Meeting

Relapsed/Refractory Multiple Myeloma — Proceedings from a Session Held During the Society of Hematologic Oncology 2026 Annual Meeting

Featuring perspectives from Dr Meletios-Athanasios (Thanos) C Dimopoulos, Dr Robert Z Orlowski and Dr Noopur Raje, moderated by Dr Orlowski, including the following topics: Introduction (0:00) New and Emerging Strategies with Bispecific Antibodies in Multiple Myeloma (MM) — Dr Raje (2:20) Utili ...
00:59:31
KONGSI
SIMPAN
Chronic Lymphocytic Leukemia — Microlearning Activity 1

Chronic Lymphocytic Leukemia — Microlearning Activity 1

Featuring perspectives from Dr Catherine C Coombs, including the following topics: Early versus delayed addition of obinutuzumab to acalabrutinib and venetoclax in treatment-naïve chronic lymphocytic leukemia (CLL) (0:00) Feasibility of discontinuation of Bruton tyrosine kinase (BTK) inhibitor ...
00:24:32
KONGSI
SIMPAN
Penafian: Podcast dan karya seni yang dibenamkan pada halaman ini adalah daripada Dr. Neil Love, yang merupakan hak milik pemiliknya dan tidak bergabung dengan atau disokong oleh Listen Notes, Inc.
PROMOTED
Listen411.com: Lightning-fast Podcast Transcription and Summarization. Transcribe 1-hour audio in under 1 minute. Pay-as-you-go.
Listen411.com: Lightning-fast Podcast Transcription and Summarization. Transcribe 1-hour audio in under 1 minute. Pay-as-you-go.
Audio to Text

SARANAN
Gunakan API untuk mendapatkan episod ini